{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:43Z","timestamp":1784408863098,"version":"3.55.0"},"reference-count":17,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.26010","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:11:08Z","timestamp":1782598268000},"page":"142-147","source":"Crossref","is-referenced-by-count":1,"title":["Independent &lt;i&gt;PML&lt;\/i&gt;::&lt;i&gt;RARA\u2013&lt;\/i&gt;positive acute promyelocytic leukemia arising during &lt;i&gt;BCR&lt;\/i&gt;::&lt;i&gt;ABL1\u2013&lt;\/i&gt;positive chronic myeloid leukemia"],"prefix":"10.3960","volume":"66","author":[{"given":"Takanori","family":"Yoshioka","sequence":"first","affiliation":[{"name":"Department of Hematology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Sando","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuharu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama University Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Sunami","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004; 103: 4010-4022.","DOI":"10.1182\/blood-2003-12-4111"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Jamieson CHM, Ailles LE, Dylla SJ <i>et al.<\/i> Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004; 351: 657-667.","DOI":"10.1056\/NEJMoa040258"},{"key":"3","unstructured":"3 Chung HJ, Chi HS, Cho YU <i>et al.<\/i> Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment. Ann Clin Lab Sci. 2008; 38: 283-286."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Parsi M, Budak-Alpdogan T. Promyelocytic blast crisis of chronic myeloid leukemia in a patient undergoing therapy with a tyrosine kinase inhibitor. Cureus. 2020; 12: e7217.","DOI":"10.7759\/cureus.7217"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Atallah E, Schiffer CA. Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom? Haematologica. 2020; 105: 2738-2745.","DOI":"10.3324\/haematol.2019.242891"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Abiyev A, Zengin O, Onder ME, Arslan S. Presentation of chronic myeloid leukemia as promyelocytic blastic transformation: a case report and literature review. Clin Case Rep Rev. 2017; 3: 348.","DOI":"10.15761\/CCRR.1000348"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wolanin S, McCall RK, Pettenati MJ <i>et al.<\/i> PML-RARA fusion transcripts detectable 8 months prior to promyelocytic blast crisis in chronic myeloid leukemia. Case Rep Hematol. 2020; 2020: 8830595.","DOI":"10.1155\/2020\/8830595"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Khoury JD, Solary E, Abla O, <i>et al.<\/i> The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022; 36: 1703-1719.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Arber DA, Orazi A, Hasserjian RP <i>et al.<\/i> International consensus classification of myeloid neoplasms and acute leukemia: integrating morphologic, clinical, and genomic data. Blood. 2022; 140: 1200-1228.","DOI":"10.1182\/blood.2022015850"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Brzozowska A, Bujko-Wasiak N, Konieva Y, J\u0119drzejczak WW, Brze\u017aniakiewicz-Janus K. Acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic and major molecular responses: a case report and literature review. Acta Haematol Pol. 2024; 55: 370-371.","DOI":"10.5603\/ahp.102542"},{"key":"11","unstructured":"11 Wakim JJ, Lessard M, Strout MP. The first case of Philadelphia chromosome-negative acute promyelocytic leukemia in a patient with chronic myelogenous leukemia in complete cytogenetic response. Leuk Res Rep. 2012; 1: 27-29."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Inokura K, Onishi Y, Shimosegawa K <i>et al.<\/i> Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor. Ann Hematol. 2012; 91: 1825-1826.","DOI":"10.1007\/s00277-012-1477-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 O\u2019Dwyer ME, Gatter KM, Loriaux M <i>et al.<\/i> Demonstration of Philadelphia chromosome-negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia. 2003; 17: 481-487.","DOI":"10.1038\/sj.leu.2402848"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Capelli D, Menotti D, Fiorentini A, <i>et al.<\/i> Secondary acute myeloid leukemia: pathogenesis and treatment. In: Li W (ed). Leukemia. Brisbane (AU), Exon Publications. 2022; Chapter 7.","DOI":"10.36255\/exon-publications-leukemia-secondary-acute-myeloid-leukemia"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ito K, Bernardi R, Morotti A <i>et al.<\/i> PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 2008; 453: 1072-1078.","DOI":"10.1038\/nature07016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Mao JH, Sun XY, Liu JX <i>et al.<\/i> As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia. Proc Natl Acad Sci U S A. 2010; 107: 21683-21688.","DOI":"10.1073\/pnas.1016311108"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Goussetis DJ, Gounaris E, Wu EJ <i>et al.<\/i> Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood. 2012; 120: 3555-3562.","DOI":"10.1182\/blood-2012-01-402578"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26010\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:12:24Z","timestamp":1783141944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26010\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.26010","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26010"}}